- Home
- FBIO vs ONCY Comparison
FBIO vs ONCY Comparison
Compare FBIO & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- ONCY
- Stock Information
- Founded
- FBIO 2006
- ONCY 1998
- Country
- FBIO United States
- ONCY Canada
- Employees
- FBIO N/A
- ONCY N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- ONCY Pharmaceuticals and Biotechnology
- Sector
- FBIO Health Care
- ONCY Health Care
- Exchange
- FBIO Nasdaq
- ONCY Nasdaq
- Market Cap
- FBIO N/A
- ONCY 53.6M
- IPO Year
- FBIO N/A
- ONCY 1999
- Fundamental
- Price
- FBIO $1.56
- ONCY $0.56
- Analyst Decision
- FBIO Strong Buy
- ONCY Strong Buy
- Analyst Count
- FBIO 3
- ONCY 4
- Target Price
- FBIO $21.00
- ONCY $4.00
- AVG Volume (30 Days)
- FBIO 382.3K
- ONCY 224.8K
- Earning Date
- FBIO 05-14-2025
- ONCY 03-07-2025
- Dividend Yield
- FBIO N/A
- ONCY N/A
- EPS Growth
- FBIO N/A
- ONCY N/A
- EPS
- FBIO N/A
- ONCY N/A
- Revenue
- FBIO $81,501,000.00
- ONCY N/A
- Revenue This Year
- FBIO N/A
- ONCY N/A
- Revenue Next Year
- FBIO $128.63
- ONCY N/A
- P/E Ratio
- FBIO N/A
- ONCY N/A
- Revenue Growth
- FBIO 31.52
- ONCY N/A
- 52 Week Low
- FBIO $1.36
- ONCY $0.55
- 52 Week High
- FBIO $2.89
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- FBIO 39.86
- ONCY 27.91
- Support Level
- FBIO $1.59
- ONCY $0.58
- Resistance Level
- FBIO $1.83
- ONCY $0.65
- Average True Range (ATR)
- FBIO 0.12
- ONCY 0.03
- MACD
- FBIO -0.01
- ONCY -0.00
- Stochastic Oscillator
- FBIO 22.86
- ONCY 1.34
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.